Boehringer Ingelheim CEO: "The Pfizer model is a failure"
The chief executive of independent German drug maker Boehringer Ingelheim said today that a merger and acquisitions strategy, as the one pursued by Pfizer, doesn't work.
"The Pfizer model is a failure," Alessandro Banchi stated, and his finance chief piled on: "We don't buy sales. We buy R&D."
Full story here.